Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2009 045 951.1 |
96 | EP file number | EAKZ | 14 00 1862.3 |
97 | EP publication number | EPN | 2772249 |
54 | Designation/title | TI | Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom |
51 | IPC main class | ICM (ICMV) | A61K 9/08 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 47/10 (2006.01), A61K 47/26 (2006.01), A61K 47/18 (2006.01), A61K 31/5575 (2006.01) |
22 | DE application date | DAT | May 28, 2009 |
96 | EP application date | EAT | May 28, 2009 |
43 | Date of first publication | OT | Sep 3, 2014 |
| Date of publication of grant | PET | May 3, 2017 |
71/73 | Applicant/owner | INH | AGC Inc., Tokyo, JP; Santen Pharmaceutical Co., Ltd., Osaka-shi, JP |
72 | Inventor | IN | Reunamaki, Timo, 33820 Tampere, FI; Pellinen, Pertti, 33880 Lempaala, FI; Oksala, Olli, 33240 Tampere, FI; Lehmussaari, Kari, 33580 Tampere, FI |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 08397513 May 30, 2008
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002772249 Searchable text:
EP000002772249 Original document:
EP000002772249B1 Searchable text:
EP000002772249B1 |
43 | Date of first publication | EVT | Sep 3, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Oct 17, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 30, 2023 (Show all update days)(Hide all update days)- Jun 30, 2023; Jun 22, 2023; Apr 19, 2023; Apr 13, 2022; Nov 24, 2021; May 12, 2021; May 19, 2020; Aug 16, 2019; May 23, 2019; Oct 31, 2018; Sep 25, 2018; May 29, 2018; Apr 5, 2018; Mar 1, 2018; Jun 8, 2017; May 5, 2017; May 4, 2017; Apr 25, 2017; Jan 12, 2017
- Historical data not available for this/these date(s)
- Oct 17, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 24, 2018 |
| Issue number | HN | 44 |
| Year | PJ | 2018 |
| Publication date | VT | Oct 31, 2018 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | AGC Inc., Tokyo, JP; Santen Pharmaceutical Co., Ltd., Osaka-shi, JP |
71/73 | Previous applicant/owner | INHF | Asahi Glass Company, Limited, Tokyo, JP, Santen Pharmaceutical Co., Ltd., Osaka-shi, JP |